Developer docs
API playgroundTry for free, no card

Search company profiles

Korea Seoul Life Science Fund

Full company profile

uuid0038l9w

Namestring
Korea Seoul Life Science Fund
Websiteurl
kslsfund.com
Company typeenum
Private
Founded yearint
2011
Short descriptiontext

Korea Seoul Life Science Fund is a privately held investment entity focused on the life science sector, founded in 2011 and based in Cambridge, Massachusetts. Operational details, portfolio, fund structure, and current activity are not documented in available sources.

Operating statusenum
Operating
Ownership categoryenum
akta.pro rankint
HeadquartersCambridge, United States
HQ citystring
Cambridge
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
life sciences investment, venture capital fund, Korea biotech investing, healthcare venture funding, Seoul life science fund
Industry2 codes
1Private Banking & UHNW Wealth Advisory
CodeFSAEABACPrimaryYes
2Private Banking Advisory & Discretionary Portfolio Management
CodeFSABADADPrimaryNo
NAICS code1 code
  • Portfolio Management and Investment Advice523940
SIC code1 code
  • Investment Advice6282
Product category
Life Sciences Venture Capital
Social media profiles1 record
Cost components1 value
Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Based on the company name and firmographics, Korea Seoul Life Science Fund appears to be a private investment vehicle focused on life sciences opportunities in the Seoul, Korea market. The company's website (kslsfund.com) currently shows only a default BlueHost hosting placeholder page with no substantive information about specific fund offerings, strategy, or portfolio.

Differentiator
Functional benefit
Problem solved
Product and service1 record
1Korea Seoul Life Science Fund (implied investment vehicle)
No data
Peers10 records
TypeDirect peer
Description

Cambridge-based early-stage life science venture capital firm. Directly comparable to Korea Seoul Life Science Fund as a Cambridge-located, life science-focused VC with a similar niche thematic mandate.

TypeBroad incumbent
Description

Large, established life science and technology venture capital firm. Comparable as a broader incumbent in the same life science VC category, with much greater AUM and longer track record.

TypeBroad incumbent
Description

Global healthcare-dedicated investment firm with multi-strategy funds across venture, growth, and credit. Comparable as a broader incumbent in the life science/healthcare investment category.

TypeDirect peer
Description

Cambridge-based biotech venture creation firm. Operating in the same Cambridge life science VC ecosystem with a focus on founding and funding biotech companies, making it a directly comparable peer.

TypeDirect peer
Description

Boston-based investment firm focused on healthcare and life sciences. Highly comparable given shared thematic focus on life sciences and Boston/Cambridge operational base.

TypeDirect peer
Description

Boston/Cambridge-based life sciences venture capital firm that builds biotech companies. Comparable in geography, sector focus, and lifecycle-stage mandate to the subject fund.

TypeDirect peer
Description

Life sciences-focused venture capital firm. Directly comparable in sector focus and fund-stage mandate, with similar thematic investing in biotech therapeutics.

TypeDirect peer
Description

Early-stage life sciences venture capital firm with offices in Boston and San Francisco. Comparable in focus area (early-stage life sciences) and in being a smaller, focused manager.

TypeEmerging player
Description

Korea-based venture capital and growth investment firm with life sciences exposure. Comparable as a peer given the Korean nexus implied by the subject firm's name, serving as a regional/emerging cross-border counterpart.

TypeDirect peer
Description

Boston-based venture capital firm with a dedicated life sciences practice. Comparable as a multi-stage investor in healthcare and biotech headquartered in the same Cambridge/Boston innovation corridor.

Market position
Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment2 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Korea Seoul Life Science Fund

Life Sciences Venture Capitalkslsfund.com

Korea Seoul Life Science Fund is a privately held investment entity focused on the life science sector, founded in 2011 and based in Cambridge, Massachusetts. Operational details, portfolio, fund structure, and current activity are not documented in available sources.

Korea Seoul Life Science Fund firmographics

Firmographics
Name
Korea Seoul Life Science Fund
Website
https://kslsfund.com
Company type
Private
Founded year
2011
Operating status
Operating
Short description
Korea Seoul Life Science Fund is a privately held investment entity focused on the life science sector, founded in 2011 and based in Cambridge, Massachusetts. Operational details, portfolio, fund structure, and current activity are not documented in available sources.
Ownership category
akta.pro rank

Korea Seoul Life Science Fund industry classification

Industry
Product category
Life Sciences Venture Capital
NAICS
Portfolio Management and Investment Advice (523940)
SIC
Investment Advice (6282)
akta.pro primary industry
Private Banking & UHNW Wealth Advisory (FSAEABAC)
akta.pro secondary industry
Private Banking Advisory & Discretionary Portfolio Management (FSABADAD)

Keywords

  • Life sciences investment
  • Venture capital fund
  • Korea biotech investing
  • Healthcare venture funding
  • Seoul life science fund

Where Korea Seoul Life Science Fund is headquartered

Location

Headquarters

HQ city
Cambridge
HQ country
United States
HQ region
North America

Markets served

Korea Seoul Life Science Fund business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Others

Korea Seoul Life Science Fund product offering

Product offering

Core offering

Based on the company name and firmographics, Korea Seoul Life Science Fund appears to be a private investment vehicle focused on life sciences opportunities in the Seoul, Korea market. The company's website (kslsfund.com) currently shows only a default BlueHost hosting placeholder page with no substantive information about specific fund offerings, strategy, or portfolio.

Differentiator

Problem solved

Functional benefit

Products and services

  • Korea Seoul Life Science Fund (implied investment vehicle)

Companies that use Korea Seoul Life Science Fund

Customer profile

Ideal customer profiles1 record

Korea Seoul Life Science Fund technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Korea Seoul Life Science Fund competitors and assessment

Company assessment

Direct peers

  • Atlas Venture: Cambridge-based early-stage life science venture capital firm. Directly comparable to Korea Seoul Life Science Fund as a Cambridge-located, life science-focused VC with a similar niche thematic mandate.
  • Flagship Pioneering: Cambridge-based biotech venture creation firm. Operating in the same Cambridge life science VC ecosystem with a focus on founding and funding biotech companies, making it a directly comparable peer.
  • RA Capital Management: Boston-based investment firm focused on healthcare and life sciences. Highly comparable given shared thematic focus on life sciences and Boston/Cambridge operational base.
  • Third Rock Ventures: Boston/Cambridge-based life sciences venture capital firm that builds biotech companies. Comparable in geography, sector focus, and lifecycle-stage mandate to the subject fund.
  • venBio Partners: Life sciences-focused venture capital firm. Directly comparable in sector focus and fund-stage mandate, with similar thematic investing in biotech therapeutics.
  • 5AM Ventures: Early-stage life sciences venture capital firm with offices in Boston and San Francisco. Comparable in focus area (early-stage life sciences) and in being a smaller, focused manager.
  • Polaris Partners: Boston-based venture capital firm with a dedicated life sciences practice. Comparable as a multi-stage investor in healthcare and biotech headquartered in the same Cambridge/Boston innovation corridor.

Broad incumbents

  • ARCH Venture Partners: Large, established life science and technology venture capital firm. Comparable as a broader incumbent in the same life science VC category, with much greater AUM and longer track record.
  • OrbiMed Advisors: Global healthcare-dedicated investment firm with multi-strategy funds across venture, growth, and credit. Comparable as a broader incumbent in the life science/healthcare investment category.

Emerging players

  • KB Investment: Korea-based venture capital and growth investment firm with life sciences exposure. Comparable as a peer given the Korean nexus implied by the subject firm's name, serving as a regional/emerging cross-border counterpart.

Market position

Customer concentration

Korea Seoul Life Science Fund social profiles

Digital presence

Korea Seoul Life Science Fund financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Korea Seoul Life Science Fund leadership team

Management profile

Number of profiles

Korea Seoul Life Science Fund funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Korea Seoul Life Science Fund M&A and investment

M&A and investment

M&A

Investments2 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Korea Seoul Life Science Fund

What does Korea Seoul Life Science Fund do?

Based on the company name and firmographics, Korea Seoul Life Science Fund appears to be a private investment vehicle focused on life sciences opportunities in the Seoul, Korea market. The company's website (kslsfund.com) currently shows only a default BlueHost hosting placeholder page with no substantive information about specific fund offerings, strategy, or portfolio.

Is Korea Seoul Life Science Fund a public or private company?

Korea Seoul Life Science Fund is a private company. It is classified as unknown and is currently operating.

When was Korea Seoul Life Science Fund founded?

Korea Seoul Life Science Fund was founded in 2011.

Where is Korea Seoul Life Science Fund based?

Korea Seoul Life Science Fund is headquartered in Cambridge, United States, in the North America region.

Who are Korea Seoul Life Science Fund's main competitors?

Direct peers on record are Atlas Venture, Flagship Pioneering, RA Capital Management, Third Rock Ventures, venBio Partners, 5AM Ventures and Polaris Partners. Broad incumbents are ARCH Venture Partners and OrbiMed Advisors. KB Investment is listed as an emerging player.

Does Korea Seoul Life Science Fund have an API?

No public API is recorded for Korea Seoul Life Science Fund.

What industry is Korea Seoul Life Science Fund in?

Korea Seoul Life Science Fund's product category is Life Sciences Venture Capital. Its primary akta.pro industry code is FSAEABAC, Private Banking & UHNW Wealth Advisory, with a secondary code of FSABADAD, Private Banking Advisory & Discretionary Portfolio Management. Its NAICS code is 523940 and its SIC code is 6282.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales